Healthcare Sector Stocks
The Healthcare sector has a total of 1059 stocks, with a combined market cap of $8.39 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.70.
Market Cap
8.39T
Revenue
4.59T
Profits
201.24B
PE Ratio
41.70
Profit Margin
4.38%
Dividend Yield
0.42%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 985.37B | -1.93% | 4,603,029 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 542.42B | -2.37% | 13,901,494 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 384.67B | -0.42% | 7,620,822 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 345.38B | -0.58% | 10,262,269 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 293.22B | -0.98% | 16,599,390 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 288.46B | 0.18% | 1,499,236 | 60.44B |
| 7 | NVS | Novartis AG | 275.93B | -0.81% | 1,635,434 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 202.87B | 0.15% | 10,986,402 | 50.57B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 183.03B | 1.09% | 4,184,392 | 45.20B |
| 10 | AMGN | Amgen Inc. | 181.77B | 0.09% | 2,954,439 | 37.22B |
| 11 | GILD | Gilead Sciences, Inc. | 166.90B | -1.31% | 17,510,274 | 29.74B |
| 12 | ISRG | Intuitive Surgical, Inc. | 150.39B | 0.24% | 3,441,380 | 10.58B |
| 13 | PFE | Pfizer Inc. | 149.21B | 0.15% | 48,284,181 | 63.32B |
| 14 | ABT | Abbott Laboratories | 149.10B | -0.81% | 21,146,667 | 45.13B |
| 15 | DHR | Danaher Corporation | 129.29B | 1.13% | 6,993,157 | 24.78B |
| 16 | SYK | Stryker Corporation | 116.96B | -0.83% | 6,065,780 | 25.27B |
| 17 | BMY | Bristol-Myers Squibb Company | 116.77B | 0.47% | 27,567,581 | 48.48B |
| 18 | CVS | CVS Health Corporation | 116.08B | -2.14% | 9,729,969 | 405.62B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 113.59B | -0.10% | 1,893,380 | 12.22B |
| 20 | SNY | Sanofi | 105.54B | -1.40% | 2,426,342 | 54.60B |
| 21 | GSK | GSK plc | 101.21B | -1.37% | 2,798,032 | 43.29B |
| 22 | MDT | Medtronic plc | 94.76B | -2.33% | 22,243,504 | 35.48B |
| 23 | MCK | McKesson Corporation | 89.24B | -1.92% | 1,938,630 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 85.39B | 0.11% | 2,469,743 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 83.98B | -1.52% | 2,352,686 | 76.39B |
| 26 | CI | The Cigna Group | 73.38B | -2.44% | 2,400,178 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 71.81B | -1.63% | 37,280,149 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 62.55B | -1.08% | 2,187,707 | 14.92B |
| 29 | COR | Cencora, Inc. | 52.41B | 0.62% | 3,105,146 | 328.68B |
| 30 | ARGX | argenx SE | 51.98B | -0.30% | 192,485 | 4.74B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 50.80B | -1.18% | 2,276,019 | 28.34B |
| 32 | EW | Edwards Lifesciences Corporation | 49.79B | 0.59% | 7,270,721 | 6.30B |
| 33 | MDLN | Medline Inc. | 48.03B | -0.65% | 33,135,243 | 29.14B |
| 34 | CAH | Cardinal Health, Inc. | 46.09B | -1.53% | 3,132,473 | 250.74B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 44.45B | -0.79% | 1,417,152 | 4.45B |
| 36 | TEVA | Teva Pharmaceutical Industries Limited | 41.13B | 2.32% | 16,852,843 | 17.35B |
| 37 | BDX | Becton, Dickinson and Company | 40.54B | -0.87% | 3,728,410 | 22.23B |
| 38 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.32B | -1.01% | 2,278,070 | 4.29B |
| 39 | HLN | Haleon plc | 40.20B | -1.63% | 7,227,064 | 14.85B |
| 40 | A | Agilent Technologies, Inc. | 38.25B | 0.11% | 4,989,566 | 7.23B |
| 41 | WAT | Waters Corporation | 37.66B | 4.61% | 3,019,772 | 3.77B |
| 42 | HUM | Humana Inc. | 36.67B | -1.06% | 1,575,421 | 137.20B |
| 43 | RVMD | Revolution Medicines, Inc. | 33.48B | 1.84% | 6,661,368 | - |
| 44 | ZTS | Zoetis Inc. | 32.57B | -0.74% | 9,296,048 | 9.53B |
| 45 | ALC | Alcon Inc. | 32.51B | 0.96% | 2,878,091 | 10.63B |
| 46 | RPRX | Royalty Pharma plc | 32.11B | 2.35% | 17,987,931 | 2.44B |
| 47 | ONC | BeOne Medicines AG | 32.01B | -0.92% | 174,818 | 5.70B |
| 48 | NTRA | Natera, Inc. | 31.99B | 4.41% | 2,691,331 | 2.50B |
| 49 | IQV | IQVIA Holdings Inc. | 30.41B | 0.62% | 2,597,517 | 16.63B |
| 50 | CNC | Centene Corporation | 29.43B | 1.17% | 7,905,901 | 178.33B |
| 51 | BIIB | Biogen Inc. | 28.94B | -0.20% | 1,905,489 | 9.94B |
| 52 | DXCM | DexCom, Inc. | 28.45B | 1.94% | 9,261,237 | 4.82B |
| 53 | VEEV | Veeva Systems Inc. | 28.45B | 6.06% | 5,109,577 | 3.20B |
| 54 | GEHC | GE HealthCare Technologies Inc. | 28.36B | -0.83% | 5,615,619 | 20.98B |
| 55 | RMD | ResMed Inc. | 27.64B | -6.32% | 3,528,085 | 5.54B |
| 56 | PHG | Koninklijke Philips N.V. | 25.43B | -0.23% | 969,996 | 20.34B |
| 57 | ILMN | Illumina, Inc. | 24.66B | 2.68% | 2,567,706 | 4.39B |
| 58 | BNTX | BioNTech SE | 24.26B | 2.69% | 1,373,492 | 3.23B |
| 59 | MTD | Mettler-Toledo International Inc. | 23.86B | 1.47% | 509,217 | 4.09B |
| 60 | UTHR | United Therapeutics Corporation | 23.64B | -0.94% | 657,447 | 3.17B |
| 61 | INSM | Insmed Incorporated | 23.17B | -1.35% | 4,534,777 | 819.56M |
| 62 | WST | West Pharmaceutical Services, Inc. | 22.81B | 0.31% | 1,307,857 | 3.22B |
| 63 | DGX | Quest Diagnostics Incorporated | 21.57B | -0.66% | 1,264,322 | 11.28B |
| 64 | ROIV | Roivant Sciences Ltd. | 21.57B | 0.37% | 7,734,984 | 8.26M |
| 65 | LH | Labcorp Holdings Inc. | 21.32B | -0.75% | 930,451 | 14.14B |
| 66 | STE | STERIS plc | 20.76B | -1.24% | 1,087,675 | 5.94B |
| 67 | INCY | Incyte Corporation | 19.33B | -0.78% | 2,903,015 | 5.36B |
| 68 | VTRS | Viatris Inc. | 18.94B | 0.93% | 16,928,307 | 14.56B |
| 69 | MRNA | Moderna, Inc. | 18.72B | -0.80% | 6,318,429 | 2.23B |
| 70 | GH | Guardant Health, Inc. | 17.20B | -2.65% | 3,513,787 | 1.08B |
| 71 | GMAB | Genmab A/S | 16.34B | -2.63% | 2,199,583 | 3.90B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 15.93B | -0.59% | 3,216,690 | 8.41B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 15.92B | 1.22% | 1,907,857 | 3.10B |
| 74 | THC | Tenet Healthcare Corporation | 15.10B | 1.22% | 1,420,927 | 21.46B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 14.84B | 0.47% | 1,766,245 | 4.44B |
| 76 | ASND | Ascendis Pharma A/S | 13.92B | -5.63% | 1,266,181 | 998.25M |
| 77 | SMMT | Summit Therapeutics Inc. | 13.61B | 0.75% | 7,214,025 | - |
| 78 | SOLV | Solventum Corporation | 12.98B | -1.30% | 12,832,510 | 8.26B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 12.98B | -3.20% | 3,052,325 | 579.96M |
| 80 | SNN | Smith & Nephew plc | 12.79B | -0.27% | 814,932 | 6.16B |
| 81 | MEDP | Medpace Holdings, Inc. | 12.77B | -0.23% | 288,607 | 2.68B |
| 82 | EXEL | Exelixis, Inc. | 12.69B | -1.89% | 2,951,594 | 2.38B |
| 83 | BTSG | BrightSpring Health Services, Inc. | 12.68B | 1.40% | 3,007,501 | 13.65B |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 12.64B | -1.07% | 1,675,661 | 1.06B |
| 85 | ALGN | Align Technology, Inc. | 12.53B | 0.98% | 1,155,008 | 4.10B |
| 86 | PEN | Penumbra, Inc. | 12.52B | -0.20% | 337,784 | 1.45B |
| 87 | DVA | DaVita Inc. | 12.48B | -1.39% | 984,124 | 13.84B |
| 88 | AXSM | Axsome Therapeutics, Inc. | 12.07B | 0.71% | 913,892 | 708.24M |
| 89 | COO | The Cooper Companies, Inc. | 11.94B | 0.28% | 5,714,878 | 4.15B |
| 90 | ELAN | Elanco Animal Health Incorporated | 11.91B | -0.54% | 10,587,525 | 4.89B |
| 91 | RGC | Regencell Bioscience Holdings Limited | 11.84B | -0.87% | 71,434 | - |
| 92 | FMS | Fresenius Medical Care AG | 11.67B | -0.28% | 1,393,763 | 22.32B |
| 93 | RVTY | Revvity, Inc. | 11.66B | 3.29% | 2,338,254 | 2.90B |
| 94 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.46B | -3.62% | 436,008 | 1.13B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 11.45B | 0.81% | 1,598,052 | 3.58B |
| 96 | GMED | Globus Medical, Inc. | 11.11B | -0.69% | 1,965,536 | 3.10B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 11.07B | 8.63% | 5,467,663 | 3.24B |
| 98 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.97B | -1.44% | 1,441,917 | 622.01M |
| 99 | ABVX | ABIVAX Société Anonyme | 10.56B | 2.42% | 1,886,466 | 5.67M |
| 100 | EHC | Encompass Health Corporation | 10.50B | 0.47% | 854,553 | 6.07B |
| 101 | CYTK | Cytokinetics, Incorporated | 10.42B | -0.07% | 1,844,619 | 105.82M |
| 102 | ICLR | ICON Public Limited Company | 10.42B | -0.53% | 1,581,297 | 8.25B |
| 103 | PODD | Insulet Corporation | 10.04B | 1.61% | 2,077,968 | 2.90B |
| 104 | PRAX | Praxis Precision Medicines, Inc. | 9.76B | -0.75% | 399,815 | 7.46M |
| 105 | ENSG | The Ensign Group, Inc. | 9.72B | -1.92% | 571,425 | 5.27B |
| 106 | BAX | Baxter International Inc. | 9.70B | - | 8,489,137 | 11.32B |
| 107 | MASI | Masimo Corporation | 9.34B | - | 824,696 | 1.56B |
| 108 | KRYS | Krystal Biotech, Inc. | 9.11B | -0.41% | 226,325 | 417.30M |
| 109 | TEM | Tempus AI, Inc. | 9.06B | -1.60% | 11,808,058 | 1.36B |
| 110 | MOH | Molina Healthcare, Inc. | 9.04B | -2.48% | 1,069,918 | 43.10B |
| 111 | BRKR | Bruker Corporation | 8.96B | 8.27% | 6,051,594 | 3.46B |
| 112 | UHS | Universal Health Services, Inc. | 8.84B | -2.67% | 4,856,175 | 17.76B |
| 113 | HSIC | Henry Schein, Inc. | 8.72B | 0.34% | 2,454,474 | 13.38B |
| 114 | NUVL | Nuvalent, Inc. | 8.72B | 1.02% | 1,169,579 | - |
| 115 | CRL | Charles River Laboratories International, Inc. | 8.70B | -0.35% | 1,041,006 | 4.03B |
| 116 | BIO | Bio-Rad Laboratories, Inc. | 8.36B | -1.80% | 521,588 | 2.59B |
| 117 | TECH | Bio-Techne Corporation | 8.09B | 1.65% | 2,928,102 | 1.21B |
| 118 | HALO | Halozyme Therapeutics, Inc. | 7.89B | -2.41% | 1,917,481 | 1.51B |
| 119 | IBRX | ImmunityBio, Inc. | 7.88B | -2.59% | 15,617,375 | 140.98M |
| 120 | QGEN | Qiagen N.V. | 7.57B | -0.14% | 3,046,509 | 2.10B |
| 121 | CORT | Corcept Therapeutics Incorporated | 7.46B | 1.62% | 775,040 | 769.10M |
| 122 | PCVX | Vaxcyte, Inc. | 7.42B | 0.67% | 1,414,021 | - |
| 123 | ATR | AptarGroup, Inc. | 7.39B | -0.12% | 559,602 | 3.87B |
| 124 | HQY | HealthEquity, Inc. | 7.36B | -2.79% | 2,826,507 | 1.34B |
| 125 | ALKS | Alkermes plc | 7.03B | 5.63% | 4,269,429 | 1.56B |
| 126 | RGEN | Repligen Corporation | 6.99B | 0.99% | 925,602 | 763.34M |
| 127 | IMVT | Immunovant, Inc. | 6.84B | -0.60% | 1,808,443 | - |
| 128 | KYMR | Kymera Therapeutics, Inc. | 6.70B | -0.05% | 587,343 | 51.48M |
| 129 | OSCR | Oscar Health, Inc. | 6.70B | -0.45% | 5,485,800 | 13.30B |
| 130 | GRFS | Grifols, S.A. | 6.66B | -1.63% | 626,427 | 8.58B |
| 131 | CELC | Celcuity Inc. | 6.48B | 1.50% | 1,419,272 | - |
| 132 | LNTH | Lantheus Holdings, Inc. | 6.47B | -0.32% | 1,376,640 | 1.55B |
| 133 | PTGX | Protagonist Therapeutics, Inc. | 6.40B | -0.85% | 597,779 | 74.06M |
| 134 | SYRE | Spyre Therapeutics, Inc. | 6.38B | 1.93% | 1,113,790 | - |
| 135 | AVTR | Avantor, Inc. | 6.23B | -0.33% | 13,814,307 | 6.55B |
| 136 | MIRM | Mirum Pharmaceuticals, Inc. | 6.19B | 1.91% | 1,370,037 | 569.61M |
| 137 | APGE | Apogee Therapeutics, Inc. | 6.16B | 5.55% | 1,417,277 | - |
| 138 | CNTA | Centessa Pharmaceuticals plc | 6.15B | -0.13% | 922,345 | 15.00M |
| 139 | PTCT | PTC Therapeutics, Inc. | 6.13B | 3.94% | 1,211,041 | 827.11M |
| 140 | GKOS | Glaukos Corporation | 6.07B | -2.98% | 1,708,764 | 551.35M |
| 141 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.05B | -5.01% | 757,903 | 217.17M |
| 142 | HIMS | Hims & Hers Health, Inc. | 6.05B | 3.03% | 20,737,851 | 2.37B |
| 143 | COGT | Cogent Biosciences, Inc. | 5.98B | -1.19% | 2,948,791 | - |
| 144 | SRRK | Scholar Rock Holding Corporation | 5.91B | -1.04% | 2,141,148 | - |
| 145 | PACS | PACS Group, Inc. | 5.80B | -3.55% | 1,026,895 | 5.43B |
| 146 | TFX | Teleflex Incorporated | 5.69B | -0.79% | 549,491 | 2.13B |
| 147 | BLTE | Belite Bio, Inc | 5.67B | -2.58% | 565,176 | - |
| 148 | CHE | Chemed Corporation | 5.64B | -3.06% | 256,954 | 2.54B |
| 149 | BLCO | Bausch + Lomb Corporation | 5.58B | 0.38% | 819,819 | 5.21B |
| 150 | LQDA | Liquidia Corporation | 5.50B | -0.27% | 1,331,285 | 288.07M |
| 151 | CGON | CG Oncology, Inc. | 5.49B | 2.57% | 1,225,931 | 5.07M |
| 152 | CRSP | CRISPR Therapeutics AG | 5.42B | -0.35% | 1,932,828 | 4.10M |
| 153 | TGTX | TG Therapeutics, Inc. | 5.38B | -2.27% | 1,224,831 | 700.35M |
| 154 | XENE | Xenon Pharmaceuticals Inc. | 5.29B | -0.11% | 1,375,299 | 7.50M |
| 155 | STVN | Stevanato Group S.p.A. | 5.09B | - | 423,509 | 1.39B |
| 156 | DNTH | Dianthus Therapeutics, Inc. | 5.08B | 2.37% | 1,248,742 | 1.34M |
| 157 | LEGN | Legend Biotech Corporation | 5.04B | -3.89% | 2,452,181 | 1.14B |
| 158 | CAI | Caris Life Sciences, Inc. | 4.73B | 0.30% | 2,186,299 | 907.29M |
| 159 | LGND | Ligand Pharmaceuticals Incorporated | 4.65B | -1.15% | 153,567 | 274.48M |
| 160 | BLLN | BillionToOne, Inc. | 4.55B | 1.22% | 406,028 | 354.54M |
| 161 | SHC | Sotera Health Company | 4.46B | -0.70% | 2,678,067 | 1.19B |
| 162 | TVTX | Travere Therapeutics, Inc. | 4.39B | -1.21% | 2,177,232 | 536.20M |
| 163 | RDNT | RadNet, Inc. | 4.37B | 0.40% | 589,209 | 2.14B |
| 164 | HNGE | Hinge Health, Inc. | 4.35B | 2.29% | 2,737,578 | 646.34M |
| 165 | MANE | Veradermics, Incorporated | 4.22B | -1.91% | 1,189,632 | - |
| 166 | AMRX | Amneal Pharmaceuticals, Inc. | 4.20B | 1.70% | 2,188,201 | 3.05B |
| 167 | TWST | Twist Bioscience Corporation | 4.16B | -3.13% | 2,133,248 | 409.48M |
| 168 | LIVN | LivaNova PLC | 4.05B | 1.04% | 708,018 | 1.43B |
| 169 | ERAS | Erasca, Inc. | 3.99B | 5.25% | 6,386,118 | - |
| 170 | NAMS | NewAmsterdam Pharma Company N.V. | 3.94B | -4.91% | 2,460,092 | 22.57M |
| 171 | DOCS | Doximity, Inc. | 3.91B | 1.57% | 4,095,260 | 644.86M |
| 172 | NVST | Envista Holdings Corporation | 3.83B | -0.51% | 4,524,785 | 2.81B |
| 173 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.82B | -0.19% | 2,605,217 | 596.96M |
| 174 | WAY | Waystar Holding Corp. | 3.82B | 2.68% | 2,197,023 | 1.16B |
| 175 | VKTX | Viking Therapeutics, Inc. | 3.80B | 1.71% | 1,747,728 | - |
| 176 | MMSI | Merit Medical Systems, Inc. | 3.76B | -1.08% | 880,175 | 1.54B |
| 177 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.75B | -1.28% | 1,931,201 | 18.07M |
| 178 | IRTC | iRhythm Holdings, Inc. | 3.74B | -1.48% | 320,374 | 787.85M |
| 179 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.72B | -4.84% | 722,265 | 754.05M |
| 180 | ACAD | ACADIA Pharmaceuticals Inc. | 3.71B | 0.14% | 1,745,373 | 1.10B |
| 181 | VCYT | Veracyte, Inc. | 3.70B | -3.44% | 1,232,886 | 541.74M |
| 182 | EWTX | Edgewise Therapeutics, Inc. | 3.68B | 2.58% | 1,167,043 | - |
| 183 | TXG | 10x Genomics, Inc. | 3.59B | 1.13% | 2,916,110 | 638.78M |
| 184 | ORKA | Oruka Therapeutics, Inc. | 3.53B | 0.95% | 1,229,292 | - |
| 185 | OGN | Organon & Co. | 3.50B | -0.07% | 5,416,877 | 6.16B |
| 186 | ICUI | ICU Medical, Inc. | 3.38B | -2.51% | 296,549 | 2.16B |
| 187 | MMED | MiniMed Group, Inc. | 3.38B | 4.60% | 574,190 | 2.99B |
| 188 | DNLI | Denali Therapeutics Inc. | 3.34B | 0.43% | 1,699,843 | - |
| 189 | BEAM | Beam Therapeutics Inc. | 3.28B | 0.40% | 1,798,788 | 164.01M |
| 190 | OPCH | Option Care Health, Inc. | 3.28B | -3.29% | 2,359,926 | 5.67B |
| 191 | DYN | Dyne Therapeutics, Inc. | 3.20B | 4.15% | 1,502,468 | - |
| 192 | RCUS | Arcus Biosciences, Inc. | 3.19B | 3.51% | 2,182,177 | 236.00M |
| 193 | CON | Concentra Group Holdings Parent, Inc. | 3.18B | -1.93% | 1,352,673 | 2.23B |
| 194 | TLX | Telix Pharmaceuticals Limited | 3.18B | -1.05% | 141,018 | 803.79M |
| 195 | TNGX | Tango Therapeutics, Inc. | 3.18B | 9.90% | 3,412,992 | 56.99M |
| 196 | ALHC | Alignment Healthcare, Inc. | 3.17B | -3.47% | 5,093,235 | 4.26B |
| 197 | HAE | Haemonetics Corporation | 3.08B | 1.15% | 942,519 | 1.33B |
| 198 | GRAL | GRAIL, Inc. | 3.08B | -3.03% | 1,247,745 | 156.12M |
| 199 | BKD | Brookdale Senior Living Inc. | 3.07B | -1.23% | 2,833,310 | 3.00B |
| 200 | RLAY | Relay Therapeutics, Inc. | 3.06B | 1.08% | 3,468,593 | 10.68M |
| 201 | ITGR | Integer Holdings Corporation | 3.03B | -0.74% | 787,990 | 1.86B |
| 202 | WRBY | Warby Parker Inc. | 3.01B | -4.67% | 2,928,207 | 890.57M |
| 203 | LFST | LifeStance Health Group, Inc. | 2.99B | -1.28% | 2,588,902 | 1.49B |
| 204 | KLRA | Kailera Therapeutics, Inc. | 2.97B | - | 555,945 | - |
| 205 | NHC | National HealthCare Corporation | 2.88B | -0.23% | 76,271 | 1.53B |
| 206 | GPCR | Structure Therapeutics Inc. | 2.80B | -2.07% | 507,098 | - |
| 207 | GMRS | GMR Solutions Inc. | 2.79B | -0.16% | 438,170 | 5.74B |
| 208 | ALMS | Alumis Inc. | 2.75B | 0.93% | 1,024,627 | 8.40M |
| 209 | PRVA | Privia Health Group, Inc. | 2.71B | -0.37% | 952,626 | 2.25B |
| 210 | ARQT | Arcutis Biotherapeutics, Inc. | 2.68B | 0.09% | 1,629,710 | 415.62M |
| 211 | SUPN | Supernus Pharmaceuticals, Inc. | 2.68B | -1.43% | 544,813 | 776.83M |
| 212 | HTFL | HeartFlow, Inc. | 2.67B | -2.36% | 1,731,416 | 191.42M |
| 213 | IRON | Disc Medicine, Inc. | 2.66B | -1.74% | 360,888 | - |
| 214 | DFTX | Definium Therapeutics, Inc. | 2.64B | 3.02% | 2,307,970 | - |
| 215 | MLYS | Mineralys Therapeutics, Inc. | 2.60B | -0.13% | 1,091,522 | - |
| 216 | IDYA | IDEAYA Biosciences, Inc. | 2.59B | 0.44% | 1,097,921 | 225.27M |
| 217 | TARS | Tarsus Pharmaceuticals, Inc. | 2.56B | -0.24% | 615,991 | 535.08M |
| 218 | VERA | Vera Therapeutics, Inc. | 2.55B | -0.95% | 1,035,571 | - |
| 219 | IMNM | Immunome, Inc. | 2.47B | -3.15% | 1,728,338 | 4.02M |
| 220 | CLDX | Celldex Therapeutics, Inc. | 2.47B | -0.85% | 494,673 | 865.00K |
| 221 | GRDN | Guardian Pharmacy Services, Inc. | 2.45B | -0.03% | 591,636 | 1.46B |
| 222 | ADPT | Adaptive Biotechnologies Corporation | 2.42B | -0.26% | 2,293,282 | 295.41M |
| 223 | ELVN | Enliven Therapeutics, Inc. | 2.41B | -2.66% | 747,916 | - |
| 224 | RARE | Ultragenyx Pharmaceutical Inc. | 2.35B | 2.92% | 1,844,053 | 670.00M |
| 225 | TMDX | TransMedics Group, Inc. | 2.32B | -0.93% | 1,273,009 | 635.89M |
| 226 | KOD | Kodiak Sciences Inc. | 2.29B | 1.63% | 596,666 | - |
| 227 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.26B | -2.09% | 3,232,347 | 885.72M |
| 228 | PBH | Prestige Consumer Healthcare Inc. | 2.25B | -1.94% | 720,124 | 1.09B |
| 229 | NKTR | Nektar Therapeutics | 2.19B | -0.20% | 973,386 | 55.63M |
| 230 | LMAT | LeMaitre Vascular, Inc. | 2.16B | 0.12% | 516,100 | 256.28M |
| 231 | ACHC | Acadia Healthcare Company, Inc. | 2.13B | -2.36% | 2,763,037 | 3.37B |
| 232 | PHVS | Pharvaris N.V. | 2.10B | 1.00% | 413,892 | - |
| 233 | AXGN | Axogen, Inc. | 2.10B | -2.33% | 840,945 | 238.11M |
| 234 | XRAY | DENTSPLY SIRONA Inc. | 2.10B | 1.75% | 7,723,119 | 3.68B |
| 235 | CLOV | Clover Health Investments, Corp. | 2.10B | -4.78% | 10,163,887 | 2.21B |
| 236 | ESTA | Establishment Labs Holdings Inc. | 2.08B | -3.14% | 459,257 | 229.58M |
| 237 | SEM | Select Medical Holdings Corporation | 2.05B | -0.06% | 1,268,309 | 5.52B |
| 238 | HCM | HUTCHMED (China) Limited | 2.03B | 1.96% | 88,346 | 548.51M |
| 239 | NBTX | Nanobiotix S.A. | 2.02B | -0.02% | 39,166 | 38.27M |
| 240 | TRVI | Trevi Therapeutics, Inc. | 2.01B | -2.15% | 1,007,472 | - |
| 241 | OMCL | Omnicell, Inc. | 2.01B | -1.30% | 675,917 | 1.23B |
| 242 | PGNY | Progyny, Inc. | 2.00B | -0.51% | 1,307,861 | 1.29B |
| 243 | BHC | Bausch Health Companies Inc. | 2.00B | -0.92% | 2,526,462 | 10.53B |
| 244 | MESO | Mesoblast Limited | 1.99B | 4.34% | 291,322 | 65.38M |
| 245 | ZLAB | Zai Lab Limited | 1.99B | -4.27% | 913,785 | 453.28M |
| 246 | TYRA | Tyra Biosciences, Inc. | 1.99B | 2.23% | 1,077,913 | - |
| 247 | NVCR | NovoCure Limited | 1.97B | -1.22% | 1,339,348 | 674.41M |
| 248 | OCUL | Ocular Therapeutix, Inc. | 1.97B | -1.53% | 2,405,075 | 52.04M |
| 249 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | -0.13% | 1,304,732 | 298.30M |
| 250 | NTLA | Intellia Therapeutics, Inc. | 1.97B | 2.85% | 5,540,220 | 66.09M |
| 251 | NEOG | Neogen Corporation | 1.95B | -3.55% | 4,429,517 | 870.56M |
| 252 | VRDN | Viridian Therapeutics, Inc. | 1.95B | 0.97% | 1,396,019 | 70.92M |
| 253 | SION | Sionna Therapeutics, Inc. | 1.93B | 0.05% | 645,335 | - |
| 254 | STOK | Stoke Therapeutics, Inc. | 1.93B | -2.21% | 543,779 | 32.08M |
| 255 | RXRX | Recursion Pharmaceuticals, Inc. | 1.91B | 4.36% | 29,983,556 | 66.41M |
| 256 | RAPP | Rapport Therapeutics, Inc. | 1.89B | 0.03% | 345,626 | 20.00M |
| 257 | SRPT | Sarepta Therapeutics, Inc. | 1.89B | 3.29% | 3,654,619 | 2.18B |
| 258 | ABCL | AbCellera Biologics Inc. | 1.88B | 7.68% | 9,333,364 | 79.21M |
| 259 | LKFT | Lakefront Biotherapeutics NV | 1.88B | 0.11% | 117,842 | 1.20B |
| 260 | ASTH | Astrana Health, Inc. | 1.87B | -1.85% | 388,204 | 3.53B |
| 261 | ADMA | ADMA Biologics, Inc. | 1.85B | 0.63% | 3,100,170 | 509.86M |
| 262 | NRIX | Nurix Therapeutics, Inc. | 1.84B | 0.51% | 1,157,210 | 71.78M |
| 263 | ZYME | Zymeworks Inc. | 1.84B | -1.37% | 585,870 | 81.26M |
| 264 | IOVA | Iovance Biotherapeutics, Inc. | 1.83B | -4.65% | 17,279,250 | 285.61M |
| 265 | HRMY | Harmony Biosciences Holdings, Inc. | 1.83B | 0.32% | 1,035,513 | 899.11M |
| 266 | NVAX | Novavax, Inc. | 1.80B | 6.30% | 7,161,696 | 596.34M |
| 267 | QURE | uniQure N.V. | 1.80B | 14.81% | 3,554,734 | 18.09M |
| 268 | AAPG | Ascentage Pharma Group International | 1.76B | 0.65% | 15,595 | 82.08M |
| 269 | CMPS | COMPASS Pathways plc | 1.76B | 9.56% | 4,559,882 | - |
| 270 | AGIO | Agios Pharmaceuticals, Inc. | 1.75B | -3.35% | 1,434,545 | 66.05M |
| 271 | SNDX | Syndax Pharmaceuticals, Inc. | 1.74B | -0.81% | 862,046 | 217.17M |
| 272 | CAPR | Capricor Therapeutics, Inc. | 1.74B | 2.92% | 841,142 | 11.13M |
| 273 | SLS | SELLAS Life Sciences Group, Inc. | 1.73B | 1.42% | 25,866,524 | - |
| 274 | SGRY | Surgery Partners, Inc. | 1.73B | -2.12% | 1,231,479 | 3.34B |
| 275 | PLSE | Pulse Biosciences, Inc. | 1.73B | 1.05% | 268,659 | 751.00K |
| 276 | MD | Pediatrix Medical Group, Inc. | 1.73B | -0.32% | 797,562 | 1.93B |
| 277 | UFPT | UFP Technologies, Inc. | 1.70B | -3.46% | 186,265 | 608.85M |
| 278 | VCEL | Vericel Corporation | 1.70B | -2.66% | 480,629 | 292.09M |
| 279 | PVLA | Palvella Therapeutics, Inc. | 1.70B | 2.24% | 155,659 | - |
| 280 | TSHA | Taysha Gene Therapies, Inc. | 1.69B | -0.84% | 2,155,625 | 7.47M |
| 281 | GENB | Generate Biomedicines, Inc. | 1.68B | 0.23% | 443,931 | 30.30M |
| 282 | ADUS | Addus HomeCare Corporation | 1.68B | -1.98% | 164,552 | 1.45B |
| 283 | GLUE | Monte Rosa Therapeutics, Inc. | 1.67B | 1.65% | 1,279,946 | 42.95M |
| 284 | ANIP | ANI Pharmaceuticals, Inc. | 1.66B | -3.21% | 429,965 | 923.71M |
| 285 | NUVB | Nuvation Bio Inc. | 1.66B | 0.63% | 4,203,135 | 143.05M |
| 286 | ATAI | AtaiBeckley Inc. | 1.66B | 2.72% | 6,028,614 | 3.49M |
| 287 | BHVN | Biohaven Ltd. | 1.66B | 7.52% | 4,891,616 | - |
| 288 | SNDA | Sonida Senior Living, Inc. | 1.65B | -2.00% | 495,606 | 367.34M |
| 289 | GHRS | GH Research PLC | 1.65B | 7.19% | 318,599 | - |
| 290 | ANAB | AnaptysBio, Inc. | 1.62B | -2.37% | 502,181 | 232.39M |
| 291 | VIR | Vir Biotechnology, Inc. | 1.61B | -0.10% | 3,089,702 | 65.50M |
| 292 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.60B | 0.91% | 923,898 | -665.00K |
| 293 | INVA | Innoviva, Inc. | 1.58B | -2.15% | 1,164,234 | 420.69M |
| 294 | AVAH | Aveanna Healthcare Holdings Inc. | 1.56B | -2.18% | 1,739,480 | 2.52B |
| 295 | PGEN | Precigen, Inc. | 1.55B | -3.77% | 5,544,092 | 31.60M |
| 296 | WGS | GeneDx Holdings Corp. | 1.54B | 3.67% | 1,143,434 | 442.68M |
| 297 | IMTX | Immatics N.V. | 1.54B | 0.52% | 430,299 | 43.00M |
| 298 | AGL | agilon health, inc. | 1.54B | 2.11% | 240,518 | 5.82B |
| 299 | DMRA | Damora Therapeutics, Inc. | 1.53B | 0.16% | 846,828 | - |
| 300 | PRGO | Perrigo Company plc | 1.53B | - | 2,351,776 | 4.18B |
| 301 | INBX | Inhibrx Biosciences, Inc. | 1.53B | 0.03% | 245,148 | 1.30M |
| 302 | NNNN | Anbio Biotechnology | 1.51B | -0.09% | 8,191 | 8.65M |
| 303 | PRCT | PROCEPT BioRobotics Corporation | 1.50B | -3.20% | 902,016 | 322.02M |
| 304 | MBX | MBX Biosciences, Inc. | 1.50B | -1.35% | 821,396 | - |
| 305 | ARDX | Ardelyx, Inc. | 1.49B | -3.36% | 2,803,812 | 427.68M |
| 306 | STAA | STAAR Surgical Company | 1.49B | 2.79% | 1,134,183 | 290.38M |
| 307 | IMCR | Immunocore Holdings plc | 1.47B | -0.28% | 505,163 | 412.81M |
| 308 | MAZE | Maze Therapeutics, Inc. | 1.46B | 0.23% | 674,490 | 20.00M |
| 309 | FTRE | Fortrea Holdings Inc. | 1.46B | 2.60% | 2,042,417 | 2.71B |
| 310 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | 0.37% | 1,334,318 | 114.48M |
| 311 | BCAX | Bicara Therapeutics Inc. | 1.43B | - | 348,672 | - |
| 312 | ALMR | Alamar Biosciences, Inc. | 1.42B | 3.44% | 402,241 | 87.16M |
| 313 | HCSG | Healthcare Services Group, Inc. | 1.41B | -0.63% | 926,867 | 1.85B |
| 314 | AVBP | ArriVent BioPharma, Inc. | 1.41B | 12.24% | 1,309,830 | - |
| 315 | ATRC | AtriCure, Inc. | 1.40B | -1.50% | 722,216 | 552.16M |
| 316 | MLTX | MoonLake Immunotherapeutics | 1.40B | 2.68% | 1,146,721 | - |
| 317 | TDOC | Teladoc Health, Inc. | 1.37B | 1.33% | 8,356,370 | 2.51B |
| 318 | URGN | UroGen Pharma Ltd. | 1.37B | -1.95% | 878,184 | 140.49M |
| 319 | NEO | NeoGenomics, Inc. | 1.37B | 3.24% | 1,939,935 | 745.97M |
| 320 | SEPN | Septerna, Inc. | 1.36B | -2.74% | 270,509 | 72.26M |
| 321 | AHCO | AdaptHealth Corp. | 1.35B | -2.13% | 1,451,889 | 3.29B |
| 322 | OCS | Oculis Holding AG | 1.34B | -23.42% | 2,856,634 | 1.51M |
| 323 | MPLT | MapLight Therapeutics, Inc. | 1.33B | -1.58% | 437,037 | - |
| 324 | ARDT | Ardent Health, Inc. | 1.32B | -2.43% | 909,476 | 6.43B |
| 325 | SVRA | Savara Inc. | 1.32B | 2.16% | 2,236,382 | - |
| 326 | HROW | Harrow, Inc. | 1.31B | -0.51% | 954,305 | 268.68M |
| 327 | ENOV | Enovis Corporation | 1.31B | -1.56% | 893,895 | 2.28B |
| 328 | AHG | Akso Health Group | 1.30B | -1.30% | 5,960 | 14.84M |
| 329 | WVE | Wave Life Sciences Ltd. | 1.27B | 1.70% | 3,549,430 | 71.80M |
| 330 | COAG | Hemab Therapeutics Holdings, Inc. | 1.26B | 1.79% | 123,660 | - |
| 331 | PAHC | Phibro Animal Health Corporation | 1.25B | -3.27% | 339,128 | 1.50B |
| 332 | IART | Integra LifeSciences Holdings Corporation | 1.25B | -2.55% | 1,197,248 | 1.64B |
| 333 | KMTS | Kestra Medical Technologies, Ltd. | 1.24B | 0.05% | 228,427 | 83.72M |
| 334 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.24B | 3.45% | 2,782,553 | 204.73M |
| 335 | BLFS | BioLife Solutions, Inc. | 1.22B | -1.31% | 904,576 | 101.66M |
| 336 | AVLN | Avalyn Pharma Inc. | 1.20B | 1.37% | 268,113 | - |
| 337 | PSNL | Personalis, Inc. | 1.19B | 3.83% | 4,471,554 | 64.52M |
| 338 | ATEC | Alphatec Holdings, Inc. | 1.19B | -1.77% | 2,613,444 | 787.08M |
| 339 | INSP | Inspire Medical Systems, Inc. | 1.19B | -3.97% | 1,131,060 | 915.25M |
| 340 | PNTG | The Pennant Group, Inc. | 1.19B | -0.32% | 285,338 | 1.02B |
| 341 | BFLY | Butterfly Network, Inc. | 1.19B | -1.30% | 3,621,238 | 102.92M |
| 342 | CDNA | CareDx, Inc. | 1.18B | 0.53% | 685,274 | 412.82M |
| 343 | TNDM | Tandem Diabetes Care, Inc. | 1.18B | 2.87% | 3,010,429 | 1.03B |
| 344 | MNKD | MannKind Corporation | 1.16B | 3.57% | 20,391,857 | 360.78M |
| 345 | ZBIO | Zenas BioPharma, Inc. | 1.16B | -0.86% | 724,826 | 10.00M |
| 346 | DBVT | DBV Technologies S.A. | 1.16B | 0.58% | 270,276 | 5.74M |
| 347 | AVNS | Avanos Medical, Inc. | 1.16B | 0.16% | 988,605 | 715.90M |
| 348 | IRMD | IRADIMED CORPORATION | 1.16B | -1.66% | 162,844 | 86.28M |
| 349 | OLMA | Olema Pharmaceuticals, Inc. | 1.15B | 3.37% | 1,607,340 | - |
| 350 | AKTS | Aktis Oncology, Inc. | 1.15B | 1.52% | 141,976 | 8.28M |
| 351 | EYPT | EyePoint, Inc. | 1.14B | 0.59% | 1,061,075 | 7.61M |
| 352 | SDGR | Schrödinger, Inc. | 1.14B | 7.34% | 2,346,706 | 254.91M |
| 353 | AMN | AMN Healthcare Services, Inc. | 1.12B | 3.72% | 1,859,146 | 3.42B |
| 354 | OPK | OPKO Health, Inc. | 1.10B | 2.10% | 2,890,120 | 581.12M |
| 355 | EVO | Evotec SE | 1.10B | 3.72% | 28,951 | 859.03M |
| 356 | COLL | Collegium Pharmaceutical, Inc. | 1.09B | 0.72% | 489,997 | 796.33M |
| 357 | AORT | Artivion, Inc. | 1.08B | -1.68% | 700,120 | 458.69M |
| 358 | CNMD | CONMED Corporation | 1.07B | 0.51% | 419,469 | 1.37B |
| 359 | OMDA | Omada Health, Inc. | 1.07B | 0.84% | 1,452,860 | 283.30M |
| 360 | CRON | Cronos Group Inc. | 1.07B | - | 1,339,092 | 159.54M |
| 361 | XERS | Xeris Biopharma Holdings, Inc. | 1.06B | -2.53% | 1,937,682 | 314.85M |
| 362 | AZTA | Azenta, Inc. | 1.05B | 1.73% | 1,427,532 | 596.48M |
| 363 | ABSI | Absci Corporation | 1.05B | 11.02% | 9,580,181 | 1.84M |
| 364 | ALVO | Alvotech | 1.05B | -2.04% | 699,179 | 562.04M |
| 365 | CRVS | Corvus Pharmaceuticals, Inc. | 1.04B | -0.72% | 3,399,031 | - |
| 366 | IVA | Inventiva S.A. | 1.04B | -5.74% | 76,191 | 7.94M |
| 367 | JBIO | Jade Biosciences, Inc. | 1.04B | 0.96% | 1,126,067 | - |
| 368 | INNV | InnovAge Holding Corp. | 1.03B | 1.07% | 298,854 | 949.17M |
| 369 | CGEM | Cullinan Therapeutics, Inc. | 1.01B | 7.03% | 1,877,764 | - |
| 370 | GDRX | GoodRx Holdings, Inc. | 988.93M | -1.68% | 1,990,634 | 787.89M |
| 371 | MGTX | MeiraGTx Holdings plc | 986.29M | 6.50% | 2,288,658 | 79.76M |
| 372 | USPH | U.S. Physical Therapy, Inc. | 977.96M | 0.58% | 195,897 | 787.69M |
| 373 | DRTS | Alpha Tau Medical Ltd. | 976.61M | 6.91% | 1,455,829 | - |
| 374 | LXRX | Lexicon Pharmaceuticals, Inc. | 968.35M | -1.36% | 1,617,878 | 69.64M |
| 375 | SPTX | Seaport Therapeutics, Inc. | 964.58M | -3.24% | 112,573 | - |
| 376 | PHAR | Pharming Group N.V. | 949.84M | -4.90% | 21,756 | 369.49M |
| 377 | SANA | Sana Biotechnology, Inc. | 918.36M | 5.43% | 5,015,969 | - |
| 378 | PCRX | Pacira BioSciences, Inc. | 913.66M | -1.94% | 511,527 | 734.86M |
| 379 | KURA | Kura Oncology, Inc. | 905.50M | 2.31% | 1,722,158 | 71.64M |
| 380 | CERT | Certara, Inc. | 905.39M | 2.65% | 4,006,165 | 419.75M |
| 381 | ABUS | Arbutus Biopharma Corporation | 900.77M | -0.87% | 2,383,772 | 191.45M |
| 382 | SPRY | ARS Pharmaceuticals, Inc. | 900.68M | -3.51% | 2,153,278 | 98.99M |
| 383 | JANX | Janux Therapeutics, Inc. | 889.76M | -1.02% | 1,051,858 | 13.73M |
| 384 | NUTX | Nutex Health Inc. | 888.45M | -1.13% | 123,707 | 879.95M |
| 385 | ANNX | Annexon, Inc. | 888.03M | 0.93% | 2,176,783 | - |
| 386 | QDEL | QuidelOrtho Corporation | 887.85M | -0.38% | 1,410,979 | 2.66B |
| 387 | INMD | InMode Ltd. | 882.59M | -0.85% | 979,829 | 374.64M |
| 388 | XNCR | Xencor, Inc. | 880.80M | -0.75% | 647,067 | 97.36M |
| 389 | DRUG | Bright Minds Biosciences Inc. | 878.77M | -1.59% | 219,614 | - |
| 390 | ORIC | ORIC Pharmaceuticals, Inc. | 874.72M | - | 3,978,569 | - |
| 391 | TALK | Talkspace, Inc. | 871.07M | 0.19% | 2,895,146 | 238.37M |
| 392 | AVTX | Avalo Therapeutics, Inc. | 838.42M | -1.12% | 1,075,998 | 59.00K |
| 393 | EVMN | Evommune, Inc. | 836.71M | -0.43% | 493,310 | 10.00M |
| 394 | ETON | Eton Pharmaceuticals, Inc. | 834.10M | -4.43% | 376,919 | 86.93M |
| 395 | AMPH | Amphastar Pharmaceuticals, Inc. | 831.15M | -2.33% | 849,068 | 720.53M |
| 396 | TBPH | Theravance Biopharma, Inc. | 827.94M | -0.93% | 531,200 | 109.78M |
| 397 | AURA | Aura Biosciences, Inc. | 823.94M | -0.40% | 439,030 | - |
| 398 | VOR | Vor Biopharma Inc. | 811.16M | -0.27% | 479,887 | - |
| 399 | ESPR | Esperion Therapeutics, Inc. | 805.76M | - | 5,309,835 | 418.24M |
| 400 | AVR | Anteris Technologies Global Corp. | 805.23M | -1.71% | 1,072,404 | 1.85M |
| 401 | ODTX | Odyssey Therapeutics, Inc. | 802.43M | -5.08% | 165,302 | 2.98M |
| 402 | LBRX | LB Pharmaceuticals Inc | 802.09M | 1.60% | 358,117 | - |
| 403 | GERN | Geron Corporation | 801.90M | - | 11,696,968 | 196.12M |
| 404 | OMER | Omeros Corporation | 799.02M | -0.99% | 2,596,693 | 9.89M |
| 405 | SSII | SS Innovations International, Inc. | 787.76M | -0.25% | 46,616 | 48.47M |
| 406 | CTMX | CytomX Therapeutics, Inc. | 783.73M | -2.96% | 2,627,145 | 35.54M |
| 407 | BIOA | BioAge Labs, Inc. | 768.59M | 1.41% | 234,178 | 10.32M |
| 408 | PHAT | Phathom Pharmaceuticals, Inc. | 761.73M | -7.07% | 1,653,986 | 204.89M |
| 409 | RLMD | Relmada Therapeutics, Inc. | 756.26M | -0.55% | 946,337 | - |
| 410 | ALLO | Allogene Therapeutics, Inc. | 748.99M | -3.56% | 10,289,550 | 22.00K |
| 411 | LMRI | Lumexa Imaging Holdings, Inc. | 747.51M | 1.04% | 633,661 | 1.03B |
| 412 | HSTM | HealthStream, Inc. | 729.50M | 1.38% | 278,077 | 311.78M |
| 413 | SLDB | Solid Biosciences Inc. | 722.62M | 3.82% | 1,268,308 | - |
| 414 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 718.56M | 1.47% | 246,379 | - |
| 415 | REPL | Replimune Group, Inc. | 717.56M | 85.68% | 51,373,461 | - |
| 416 | BVS | Bioventus Inc. | 710.88M | -4.06% | 711,367 | 576.30M |
| 417 | ANRO | Alto Neuroscience, Inc. | 703.51M | -0.74% | 170,977 | - |
| 418 | CBLL | CeriBell, Inc. | 700.04M | -1.18% | 179,574 | 95.07M |
| 419 | TENX | Tenax Therapeutics, Inc. | 698.89M | 1.54% | 390,713 | - |
| 420 | CBIO | Crescent Biopharma, Inc. | 686.18M | -3.82% | 419,767 | 11.88M |
| 421 | ZVRA | Zevra Therapeutics, Inc. | 685.14M | 1.67% | 2,260,666 | 122.29M |
| 422 | BWAY | BrainsWay Ltd. | 664.48M | 0.06% | 68,251 | 56.22M |
| 423 | CRMD | CorMedix Inc. | 662.13M | 0.24% | 1,041,519 | 400.05M |
| 424 | TLRY | Tilray Brands, Inc. | 657.25M | -2.48% | 3,320,343 | 858.28M |
| 425 | DSGN | Design Therapeutics, Inc. | 654.55M | -2.42% | 1,595,147 | - |
| 426 | SGP | SpyGlass Pharma, Inc. | 643.80M | -2.92% | 44,588 | - |
| 427 | PRME | Prime Medicine, Inc. | 641.19M | 4.41% | 3,337,658 | 4.03M |
| 428 | CSTL | Castle Biosciences, Inc. | 639.36M | -4.66% | 358,634 | 339.92M |
| 429 | ACRS | Aclaris Therapeutics, Inc. | 635.47M | -0.44% | 1,184,480 | 8.37M |
| 430 | IMMX | Immix Biopharma, Inc. | 628.12M | 1.81% | 964,011 | - |
| 431 | SIBN | SI-BONE, Inc. | 625.32M | -2.15% | 565,264 | 206.22M |
| 432 | CABA | Cabaletta Bio, Inc. | 616.35M | 0.27% | 2,536,943 | - |
| 433 | DNA | Ginkgo Bioworks Holdings, Inc. | 612.09M | -0.95% | 1,183,083 | 151.40M |
| 434 | PHR | Phreesia, Inc. | 609.47M | 4.34% | 3,516,116 | 495.59M |
| 435 | CERS | Cerus Corporation | 609.12M | 4.11% | 3,291,704 | 216.56M |
| 436 | CADL | Candel Therapeutics, Inc. | 608.14M | 2.60% | 1,366,205 | - |
| 437 | ALT | Altimmune, Inc. | 593.15M | -0.65% | 2,596,556 | 36.00K |
| 438 | TECX | Tectonic Therapeutic, Inc. | 588.06M | 4.65% | 336,472 | - |
| 439 | IRWD | Ironwood Pharmaceuticals, Inc. | 587.67M | -0.83% | 2,036,486 | 361.51M |
| 440 | EIKN | Eikon Therapeutics, Inc. | 586.86M | 5.24% | 200,879 | - |
| 441 | ARVN | Arvinas, Inc. | 579.40M | 1.58% | 795,944 | 89.40M |
| 442 | VALN | Valneva SE | 578.55M | -0.79% | 73,583 | 180.25M |
| 443 | RIGL | Rigel Pharmaceuticals, Inc. | 564.13M | 1.46% | 350,219 | 299.77M |
| 444 | NPCE | NeuroPace, Inc. | 563.91M | -4.89% | 177,850 | 99.53M |
| 445 | TRAX | First Tracks Biotherapeutics, Inc. | 556.88M | 0.88% | 471,519 | - |
| 446 | TCMD | Tactile Systems Technology, Inc. | 555.11M | -3.68% | 290,733 | 343.52M |
| 447 | AGMB | AgomAb Therapeutics NV | 554.04M | -2.51% | 17,438 | - |
| 448 | PROK | ProKidney Corp. | 552.77M | 1.10% | 1,003,687 | 889.00K |
| 449 | ASMB | Assembly Biosciences, Inc. | 548.15M | -0.25% | 138,760 | 71.10M |
| 450 | MDXG | MiMedx Group, Inc. | 548.12M | 0.27% | 3,291,829 | 389.42M |
| 451 | SRTA | Strata Critical Medical, Inc. | 545.98M | -2.47% | 699,014 | 228.58M |
| 452 | CTKB | Cytek Biosciences, Inc. | 541.11M | 1.70% | 1,029,923 | 204.17M |
| 453 | BBNX | Beta Bionics, Inc. | 540.09M | 0.17% | 430,333 | 110.24M |
| 454 | GYRE | Gyre Therapeutics, Inc. | 540.01M | 2.96% | 107,722 | 117.05M |
| 455 | ACHV | Achieve Life Sciences, Inc. | 537.93M | -1.13% | 1,099,043 | - |
| 456 | PRTA | Prothena Corporation plc | 532.96M | 2.00% | 501,435 | 57.94M |
| 457 | EDIT | Editas Medicine, Inc. | 530.98M | 0.87% | 3,912,582 | 38.69M |
| 458 | CLYM | Climb Bio, Inc. | 523.54M | -3.35% | 605,378 | - |
| 459 | XOMA | XOMA Royalty Corporation | 523.09M | 0.02% | 78,306 | 48.56M |
| 460 | FDMT | 4D Molecular Therapeutics, Inc. | 518.06M | 10.48% | 3,316,846 | 88.24M |
| 461 | KYTX | Kyverna Therapeutics, Inc. | 515.72M | -1.50% | 614,974 | - |
| 462 | FLGT | Fulgent Genetics, Inc. | 515.19M | -0.55% | 1,185,265 | 320.35M |
| 463 | OVID | Ovid Therapeutics Inc. | 509.53M | 3.41% | 1,672,992 | 7.12M |
| 464 | CTNM | Contineum Therapeutics, Inc. | 504.34M | 1.35% | 100,732 | - |
| 465 | AQST | Aquestive Therapeutics, Inc. | 504.31M | - | 1,324,064 | 50.27M |
| 466 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 467 | AUTL | Autolus Therapeutics plc | 497.69M | 5.65% | 2,402,566 | 92.62M |
| 468 | STRO | Sutro Biopharma, Inc. | 484.28M | -1.35% | 212,145 | 102.48M |
| 469 | CCCC | C4 Therapeutics, Inc. | 481.49M | 19.40% | 5,891,767 | 34.86M |
| 470 | WEAV | Weave Communications, Inc. | 478.99M | 4.51% | 957,716 | 248.72M |
| 471 | ANGO | AngioDynamics, Inc. | 478.51M | -2.63% | 248,544 | 313.73M |
| 472 | ANL | Adlai Nortye Ltd. | 477.60M | 5.66% | 105,596 | 5.00M |
| 473 | EPRX | Eupraxia Pharmaceuticals Inc. | 470.57M | -3.93% | 194,163 | - |
| 474 | EBS | Emergent BioSolutions Inc. | 470.56M | -0.65% | 1,157,303 | 676.80M |
| 475 | TOI | The Oncology Institute, Inc. | 468.92M | -0.42% | 1,538,885 | 545.76M |
| 476 | OCGN | Ocugen, Inc. | 467.16M | -2.13% | 12,730,171 | 4.47M |
| 477 | FBRX | Forte Biosciences, Inc. | 465.99M | -8.18% | 392,924 | - |
| 478 | PACB | Pacific Biosciences of California, Inc. | 462.80M | 1.36% | 7,012,526 | 160.03M |
| 479 | FULC | Fulcrum Therapeutics, Inc. | 461.10M | 1.47% | 391,024 | 80.00M |
| 480 | STTK | Shattuck Labs, Inc. | 456.25M | -0.34% | 1,044,007 | 1.00M |
| 481 | KMDA | Kamada Ltd. | 455.27M | -0.64% | 35,435 | 181.68M |
| 482 | UPB | Upstream Bio, Inc. | 454.95M | 0.48% | 499,059 | 3.32M |
| 483 | SGMT | Sagimet Biosciences Inc. | 450.17M | 0.28% | 628,245 | - |
| 484 | CATX | Perspective Therapeutics, Inc. | 449.34M | -2.72% | 893,574 | 618.00K |
| 485 | LAB | Standard BioTools Inc. | 448.92M | 0.88% | 7,024,742 | 86.26M |
| 486 | NGNE | Neurogene Inc. | 447.83M | 3.05% | 98,436 | 925.00K |
| 487 | EVH | Evolent Health, Inc. | 444.30M | 1.28% | 3,041,045 | 1.89B |
| 488 | IPSC | Century Therapeutics, Inc. | 441.87M | 2.73% | 1,196,588 | 109.16M |
| 489 | KIDS | OrthoPediatrics Corp. | 441.01M | -3.59% | 148,034 | 243.30M |
| 490 | NRC | NRC Health | 440.14M | -0.66% | 87,434 | 138.64M |
| 491 | MNPR | Monopar Therapeutics Inc. | 435.69M | 0.95% | 119,439 | - |
| 492 | MOBI | Mobia Medical, Inc. | 433.42M | 0.77% | 66,610 | 32.04M |
| 493 | ADCT | ADC Therapeutics SA | 432.45M | -1.45% | 689,880 | 79.18M |
| 494 | EOLS | Evolus, Inc. | 432.01M | -0.15% | 826,228 | 301.79M |
| 495 | VREX | Varex Imaging Corporation | 431.16M | -2.76% | 427,119 | 857.50M |
| 496 | CMPX | Compass Therapeutics, Inc. | 428.61M | -1.24% | 6,051,262 | 850.00K |
| 497 | CTEV | Claritev Corporation | 428.24M | 2.28% | 117,598 | 978.76M |
| 498 | CGC | Canopy Growth Corporation | 414.38M | -2.68% | 7,766,540 | 203.04M |
| 499 | VTVT | vTv Therapeutics Inc. | 413.86M | -0.45% | 21,371 | 36.84M |
| 500 | ZURA | Zura Bio Limited | 407.99M | 2.38% | 619,534 | - |